DISEASE INDICATIONS: Spinal Muscular Atrophy
MANUFACTURER: Biogen Idec Ltd
USAGE: Intrathecal Injection
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Spinraza (Nusinersen) is an intrathecal injection used to treat Spinal Muscular Atrophy (SMA) by increasing the production of the SMN protein, promoting the survival and health of motor neurons; this promotes improved muscle control and movement.